However, this was significantly reduced in the 2nd year to 85 %, then some gradual small change could be observed which did not reach statistical significance.
← all excerpts
NEDA-state, psychological symptoms and quality of life are stable in natalizumab-treated multiple sclerosis patients: An up to 6-years long follow-up study.
1
—
—